SALT LAKE CITY — Prostate Cancer Awareness
The phrase “more men die with prostate cancer than because of it” is frequently mentioned in discussions about the disease. While it holds some truth for certain individuals, regular screenings can indeed be life-saving.
World Prostate Cancer Day is observed on June 11. Taking a few moments to understand the symptoms and the screening process can really make a difference.
With former President Joe Biden’s diagnosis, there’s been a surge in conversations surrounding prostate cancer. However, the necessity of regular screenings remains a contentious topic in medical circles. Conflicting studies from various cancer and medical organizations complicate the issue, making it hard to determine whether frequent checks are truly essential.
Dr. David Gill, an oncologist at Intermountain Health, emphasizes the importance of viewing patients as whole individuals rather than just numbers. “A quarter of men in their 70s will reach 90. I suggest we focus on life expectancy, not just age. For men expected to live 10 years or more, I advocate for prostate cancer screenings,” he said.
Common symptoms of prostate cancer include urinary changes and increased fatigue. Since most cases emerge after age 50, these signs can often be mistaken for normal aging. Consequently, regular screenings may not be top of mind for many.
Dr. Gill has seen the significant impact of screenings firsthand. A patient undergoing treatment recently learned he has Lynch Syndrome, a condition that heightens the risk of prostate cancer. Thanks to his regular screenings, not only did he receive timely care, but he also encouraged his family to get screened.
Lynch Syndrome has a familial tendency, meaning this revelation was crucial for securing treatment for both male and female relatives.
Contrary to what some might believe, regular screenings are not overly invasive, according to Gill. The physical examination is typically reserved for advanced cases. Standard screenings generally involve a blood test that measures prostate-specific antigen (PSA) levels, which help assess the presence and severity of cancer.
In Utah, cancer rates show notable differences from national averages, primarily due to the state’s lower smoking rates. Consequently, lung cancer cases are much lower there, while prostate cancer ranks as the most common cancer among men in Utah.
While smoking escalates lung cancer risks, prostate cancer stems from various uncontrollable factors, as Gill points out. Genetic predispositions, syndromes, and race can all influence susceptibility. African American men face a higher likelihood of developing prostate cancer and should consider more frequent screenings. The timing of these screenings can significantly boost treatment effectiveness.
“A major misconception is that prostate cancer is always a slow-moving disease. Sure, many men won’t require treatment. Monitoring can be a viable option for low-risk cases. However, let’s not forget, it can also be advanced and aggressive,” Gill explained.
Gill stresses that awareness is critical in averting severe illness.
“I’d recommend two important steps: First, gather family medical history. For prostate cancer, don’t just ask the men—also inquire about any women with breast or ovarian cancer. Engaging with a primary care provider is essential. Guidelines can vary, making it a little complex, but they can facilitate that essential conversation,” he added.
For most men, Gill suggests starting screenings at age 50. Those with higher risk factors, like a family history of prostate cancer, should consider beginning screenings as early as 40.
